Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

The National Parkinson Foundation Launches New and Improved Parkinson.org

Premier website for the Parkinson's disease community

MIAMI — The National Parkinson Foundation announces today the official launch of a redesigned website, www.parkinson.org, devoted to increasing awareness and understanding of Parkinson's disease by offering free resources to people diagnosed with the disease and their families.

"More and more people are looking online for answers to their Parkinson's-related questions and the National Parkinson Foundation wants them to know that they are not alone," said Michael Okun, MD, NPF National Medical Director. "Parkinson.org is the most trusted source of information on Parkinson's and an indispensable resource for anyone living with the disease and their caregivers."

Parkinson.org provides information to help every person diagnosed with Parkinson's live their best life now. The user-friendly site explains the diagnosis of PD, the various motor and non-motor symptoms, treatments and tips for living well. Site visitors can find help and resources in their local communities, or get involved with a local fundraising event.

The newly-enhanced site features:

  • A responsive design, meaning it displays well on a tablet or a smartphone
  • A clickable resource map that features Parkinson's experts and community organizations in your area
  • Expanded blog offerings written by Parkinson's researchers, neurologists and experienced caregivers
  • Easy-to-use fundraising pages for participation in Moving Day® and Team Hope™ for Parkinson's
  • Tribute pages that honor your loved ones
  • Updated event calendar to search upcoming events in your area
  • Share your story feature
  • Latest news and the popular "Ask the Doctor" online forums
  • Online store to purchase branded awareness items and order free educational materials
  • Share pages that interest you with others across Facebook, Twitter, and email

All Parkinson.org visitors can use the special code "WEBSITE" during the month of August to receive 10% off any merchandise order at www.parkinson.org/store.

About Parkinson's Disease (PD)

Affecting an estimated one million Americans and four to six million worldwide, Parkinson's is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Monday, August 3, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.